Airway Medix S.A. entra en la fase comercial con su primer pedido internacional
El 3 de diciembre de 2025, Airway Medix recibió su primer pedido comercial, de B-Care Oral Care y Cuffix, de su socio de distribución en América Latina. El pedido marca el inicio de la fase comercial, con la producción ubicada íntegramente en Europa.
Texto completo en inglés (original)
Warsaw, December 5, 2025: Airway Medix S.A. (WSE: AWM), an innovative MedTech company focused on advanced disposable devices for mechanically ventilated patients, announces the receipt of its first commercial order under previously executed distribution agreements for its B-Care Oral Care and Cuffix devices.
On December 3, 2025, Airway Medix received its first commercial order from a company based in Latin America active in the distribution and sale of medical equipment. The order covers the Oral Care and Cuffix product lines and marks the beginning of commercial sales based on distribution contracts previously disclosed in current reports.
This milestone follows a series of key steps completed in recent months, including product certification, obtaining the ISO 13485 quality management system certificate, and the transfer of full production to Europe, which enabled the company to reach full manufacturing readiness.
"Receiving the first commercial order under our new distribution agreements is a clear validation of the business transformation we have been executing," said Anna Aranowska-Bablok, Chief Executive Officer of Airway Medix S.A. "It confirms that the investments in certification, quality systems and European manufacturing capacity are translating into revenue-generating commercialization of our portfolio, and it strengthens our confidence in the scalability of our model as we work to build a broader base of stable, recurring sales."
In line with its communicated focus on transforming from a research and development-focused entity into a fully functioning international commercial company, Airway Medix has significantly strengthened its sales and marketing team. The development of organic sales has become one of the company's key operational priorities.
About Airway Medix S.A.: Airway Medix S.A. focuses on the research, development and commercialization of innovative disposable devices for mechanically ventilated patients in Intensive Care Units (ICUs), as well as life-threatening patients and anesthesiology departments. The products offered by Airway Medix address the most pressing clinical needs and fill a gap in current medical devices. Airway Medix S.A. has been listed on the Warsaw Stock Exchange since 2014.
Las notas de prensa se publican tal como las emitió Airway Medix S.A. Las afirmaciones sobre los productos siguen las instrucciones de uso.
